{"schema_version":"1","generated_at":"2026-10-29T12:52:48.309Z","data_as_of":null,"url":"https://www.findmykol.com/kol/stephen-peeke","json_url":"https://www.findmykol.com/kol/stephen-peeke/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"stephen-peeke","name":"Stephen Peeke","credential":"MD","specialty":"Medical Oncology","specialty_raw":"Medical Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"city":"Milford","state":"DE","region":{"label":"Northeast","url":"https://www.findmykol.com/region/northeast"}},"identifiers":{"npi":"1013350297","orcid":"0000-0001-5964-5565","openalex":"A5032866353"},"summary":"Stephen Peeke is an Oncology physician. OpenAlex indexes 33 publications with 438 citations (h-index 4).","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":33,"cited_by_count":438,"h_index":4,"latest_activity_year":2026,"source":"works"},"payments":{"company_count":17,"program_years":{"first":2021,"last":null},"rows_total":30,"shown":3,"withheld":27,"rows":[{"payer":"Janssen Biotech, Inc.","program_year":2025,"amount_usd":112.63,"payment_count":3,"source_url":"https://openpaymentsdata.cms.gov/search?query=1013350297"},{"payer":"AstraZeneca Pharmaceuticals LP","program_year":2024,"amount_usd":201.35,"payment_count":5,"source_url":"https://openpaymentsdata.cms.gov/search?query=1013350297"},{"payer":"Janssen Biotech, Inc.","program_year":2024,"amount_usd":63.23,"payment_count":2,"source_url":"https://openpaymentsdata.cms.gov/search?query=1013350297"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1013350297","source":"payments"},"publications":{"total":31,"shown":5,"withheld":26,"matched_by":"OpenAlex author record","recent":[{"title":"Treatment of &lt;i&gt;TP53&lt;/i&gt;-mutated myelodysplastic syndrome and acute myeloid leukemia with lowintensity metronomic decitabine and venetoclax","year":2026,"journal":"Haematologica","source_url":"https://doi.org/10.3324/haematol.2026.300534","status":"verified"},{"title":"Beyond the peripheral count: multiorgan leukemic infiltration in the absence of hyperleukocytosis, an autopsy case report","year":2026,"journal":"Human Pathology Reports","source_url":"https://doi.org/10.1016/j.hpr.2026.300824","status":"verified"},{"title":"468 | FIRST‐IN‐HUMAN CART CELLS FOR ADULT T‐CELL LEUKEMIA/LYMPHOMA USING CTX130, A CD70‐TARGETED ALLOGENEIC CRISPR‐Cas9‐ENGINEERED CART‐CELLS. COBALT‐LYM STUDY COHORT","year":2025,"journal":"Hematological Oncology","source_url":"https://doi.org/10.1002/hon.70094_468","status":"verified"},{"title":"Adding the <scp>FcRn</scp> antagonist efgartigimod for the prevention of <scp>IgG</scp> ‐mediated complications in the peri‐transplant period","year":2025,"journal":"Transfusion","source_url":"https://doi.org/10.1111/trf.18374","status":"verified"},{"title":"Dosing decitabine and venetoclax for terminal differentiation to improve outcomes in TP53 mutant MDS and AML.","year":2025,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.2025.43.16_suppl.6514","status":"verified"}],"source":"works"},"contact":{"address_1":"100 WELLNESS WAY","city":"Milford","state":"DE","zip":"199634364","phone":"302-430-5072","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1013350297","source":"identity"},"similar":[{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Larry Norton","slug":"larry-norton","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/larry-norton","json_url":"https://www.findmykol.com/kol/larry-norton/profile.json"}],"coverage":{"note":"A basic record from the physician directory. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":27,"publications":26}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2026-02-17","provider_certified":"2026-02-17","collected_at":"2026-10-27T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"}},"methodology_url":"https://www.findmykol.com/about#methodology"}